Alimentation Couche-Tard disclosed Thursday that the Toronto Stock Exchange approved renewal of its normal-course issuer bid, authorizing repurchase of up to 74.19 million subordinate voting shares between July 2026 and July 2027. At Thursday's close of C$75.43, the authorization represents roughly C$5.6 billion in theoretical buyback capacity, though the company has consistently deployed far below regulatory maximums in prior cycles. The approval covers 9.98% of Couche-Tard's public float as of the filing date, a figure that mirrors the TSX's standard ceiling for twelve-month programs.
The renewal extends a capital-return infrastructure that Couche-Tard has operated without interruption since fiscal 2013. Under the expiring program, which runs through July 2026, the company repurchased 29.4 million shares at an average cost of C$68.12 through the third quarter of fiscal 2025, deploying roughly C$2.0 billion against a 69.8 million-share authorization. That 42% utilization rate is consistent with Couche-Tard's historical pattern: authorization acts as ceiling capacity, not deployment target. The company has repeatedly signaled that buyback pace adjusts to M&A pipeline visibility, free-cash-flow volatility, and relative valuation versus acquisition opportunities in fragmented North American and European convenience markets.
The timing matters because Couche-Tard is simultaneously pursuing its largest acquisition on record. The company's $38.5 billion non-binding proposal for Seven & i Holdings remains under review by a Tokyo special committee, with Japanese regulatory timelines extending into mid-2025 at the earliest. If that deal closes, buyback deployment would almost certainly decelerate as management digests 84,000 global convenience locations and repatriates capital for integration costs. If Seven & i rejects or a competing bid emerges, Couche-Tard's buyback authorization becomes the primary visible outlet for excess cash generation, which ran at C$1.9 billion in free cash flow over the trailing four quarters. The gap between authorization size and historical utilization also preserves optionality: management can accelerate repurchases without seeking new board or exchange approvals if valuation dislocates or if smaller bolt-on acquisitions in Scandinavia or the U.S. Southeast fail to materialize.
Allocators should monitor three catalysts over the next six months. First, Seven & i's special committee is expected to issue a formal response to Couche-Tard's revised proposal by late April or early May, which will clarify whether the buyback remains secondary to M&A or becomes the primary capital-return lever. Second, Couche-Tard's fiscal Q4 2025 earnings in late June will disclose buyback deployment under the expiring program and provide initial commentary on deployment pace under the new authorization. Third, any material deceleration in North American same-store fuel volumes—currently running flat to slightly negative—would pressure free-cash-flow generation and force a choice between buyback pace and leverage-ratio commitments. The company has historically maintained net-debt-to-EBITDA below 1.5x outside of major acquisitions, and current leverage sits near 1.2x on a trailing basis.
The authorization's July 2026 start date is the steel: Couche-Tard gets fourteen months to clarify its M&A calendar before the first share gets retired under the new program.